For the Inventor, By the Inventor

Enter assignee name

Cleveland, OH, United States of America

Gliatech, Inc.

USPTO Granted Patents = 17

Trademarks = 1

Forward Citations = 479

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Adrian Harel (8 out of 9 patents)

Dikla Roufa (8 out of 9 patents)

George T Coker, Iii (7 out of 8 patents)

4. Clark E Tedford (7 out of 7 patents)

5. Robert C Frederickson (7 out of 7 patents)

6. James G Phillips (6 out of 13 patents)

7. Amin Mohammed Khan (5 out of 9 patents)

8. Syed M Ali (3 out of 6 patents)

9. Stephen L Yates (2 out of 4 patents)

10. Kurt R Brunden (2 out of 4 patents)

11. Nishith C Chaturvedi (2 out of 8 patents)

12. Graham J Durant (1 out of 29 patents)

13. Robert C A Frederickson (1 out of 2 patents)

14. Loyd H Burgess (1 out of 1 patent)

15. Michael J Gallagher (1 out of 1 patent)

17 patents: Sort by Forward Citations

1. 6448282 - 1H-4(5)-substituted imidazole derivatives (2002-09-10),

2. 6417173 - Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers (2002-07-09),

3. 6416975 - Human glycine transporter type 2 (2002-07-09),

4. 6333034 - Process for inhibiting complement activation via the alternative pathway (2001-12-25),

5. 6166060 - 1H-4(5)-substituted imidazole derivatives (2000-12-26),

6. 6127348 - Methods and compositions based on inhibition of cell invasion and (2000-10-03),

7. 6083930 - Methods and compositions based on inhibition of cell invasion and (2000-07-04),

8. 6072057 - 1H-4(5)-cyclo-substituted imidazole derivatives as histamine H.sub.3 (2000-06-06),

9. 6020326 - Method for inhibition of bone growth by anionic polymers (2000-02-01),

10. 6008240 - 2-(1H-4(5)-imidazoyl) cyclopropyl derivatives (1999-12-28),

11. 5994325 - Methods and compositions based on inhibition of cell invasion and (1999-11-30),

12. 5990317 - 2-(1H-4(5)-imidazoyl) cyclopropyl compounds (1999-11-23),

13. 5705178 - Methods and compositions based on inhibition of cell invasion and (1998-01-06),

14. 5705177 - Methods and compositions based on inhibition of cell invasion and (1998-01-06),

15. 5652258 - 2-(4-imidazoyl) cyclopropyl derivatives (1997-07-29),

Gliatech, Inc. is a biotechnology company specializing in the development and commercialization of innovative therapies for neurological disorders. With a focus on glial cell research, Gliatech aims to provide novel treatments for conditions such as multiple sclerosis, Alzheimer's disease, and Parkinson's disease. Through cutting-edge research and collaboration with leading scientists, Gliatech is dedicated to improving the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

17 Patents

#116 in Cleveland, OH

#807 in Ohio

#18,854 in US

#35,837 in the World

Cleveland, OH, United States of America

Gliatech, Inc.

Forward Citations = 479

17 inventors:

Adrian Harel (8 out of 9 patents)

Dikla Roufa (8 out of 9 patents)

George T Coker, Iii (7 out of 8 patents)

4. Clark E Tedford (7 out of 7 patents)

5. Robert C Frederickson (7 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…